You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 5, May 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Neurogenetics
 •Alert me on articles by topic

Contribution of the Interleukin 4 Gene to Susceptibility to Subacute Sclerosing Panencephalitis

Takehiko Inoue, MD; Ryutaro Kira, MD, PhD; Futoshi Nakao, MD; Kenji Ihara, MD, PhD; Wafaa M. Bassuny, MD; Koichi Kusuhara, MD, PhD; Kenji Nihei, MD, PhD; Kenzo Takeshita, MD, PhD; Toshiro Hara, MD, PhD

Arch Neurol. 2002;59:822-827.

Background  Although the exact pathogenesis of subacute sclerosing panencephalitis (SSPE) remains to be determined, both viral and host factors seem to be involved.

Objective  To identify host genetic factors involved in the development of SSPE.

Methods  We investigated the association of polymorphisms in the T helper (Th)1 and Th2 cytokine, and related genes (interferon [IFN]-{gamma}, IFN-{gamma} receptor 1 [IFN-{gamma} R1], IFN-{gamma}R2 [IRF-1], interleukin 12 receptor {beta} 1 [IL-12R{beta}1], IL-4, IL-4R, and IL-10 genes) with SSPE in Japanese subjects.

Results  A significant association (P = .03) was observed between SSPE and the T allele of the biallelic polymorphism at position -589 in the promoter region of the IL-4 gene. The IRF-1 allele 1 tended to interact with the IL-4 promoter -589 Tgenotype in the development of SSPE (P = .06), as judged on logistic regression analysis. The frequency of the genotype combination of IL-4 promoter -589 T and IRF-1 allele 1 (at least 1 allele) in patients with SSPE was much higher than that in the controls (47.7% vs 22.0%; P = .003, {chi}2 analysis). However, there was no association between other polymorphisms and SSPE.

Conclusion  To our knowledge, this study is the first to demonstrate the possibility that the IL-4 promoter gene –589 T gene polymorphism with increased IL-4 synthesis in combination with IRF-1 allele 1 confers host genetic susceptibility to SSPE in Japanese subjects.


From the Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka (Drs Inoue, Kira, Nakao, Ihara, Bassuny, Kusuhara, and Hara), Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago (Drs Inoue and Takeshita), and the Division of Neurology, National Children's Hospital, Tokyo (Dr Nihei), Japan.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases
Oda et al.
Hum Mol Genet 2007;16:592-599.
ABSTRACT | FULL TEXT  

Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis
Torisu et al.
Neurology 2004;62:457-460.
ABSTRACT | FULL TEXT  

Combined Treatment With Subcutaneous Interferon-{alpha}, Oral Isoprinosine, and Lamivudine for Subacute Sclerosing Panencephalitis
Aydin et al.
J Child Neurol 2003;18:104-108.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.